These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9193572)

  • 1. Anti-CD4/CyA therapy causes prevention of autoimmune but not allogeneic destruction of grafted islets in BB rats.
    Kuttler B; Rösing K; Hahn HJ
    Transplant Proc; 1997 Jun; 29(4):2163-5. PubMed ID: 9193572
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevention of autoimmune but not allogeneic destruction of grafted islets by different therapeutic strategies.
    Kuttler B; Rösing K; Lehmann M; Brock J; Hahn HJ
    J Mol Med (Berl); 1999 Jan; 77(1):226-9. PubMed ID: 9930969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of mycophenolate mofetil with and without anti-CD4 (GK1.5) on fetal islet iso-, allo-, and xenografts in NOD/Lt female mice.
    Koulmanda M; Kovarik J; Mandel TE
    Transplant Proc; 1997 Jun; 29(4):2161-2. PubMed ID: 9193571
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunotherapy with nondepleting anti-CD4 monoclonal antibodies but not CD28 antagonists protects islet graft in spontaneously diabetic nod mice from autoimmune destruction and allogeneic and xenogeneic graft rejection.
    Guo Z; Wu T; Kirchhof N; Mital D; Williams JW; Azuma M; Sutherland DE; Hering BJ
    Transplantation; 2001 Jun; 71(11):1656-65. PubMed ID: 11435979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of autoimmune islet allograft destruction by engraftment of donor T cells.
    Bartlett ST; Schweitzer EJ; Kuo PC; Johnson LB; Delatorre A; Hadley GA
    Transplantation; 1997 Jan; 63(2):299-303. PubMed ID: 9020334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The importance of donor MHC compatibility in the allo- and autoimmune destruction of islet grafts in the BB rat.
    Stegall MD; Chabot JA; Tezuka K; Reemtsma K; Hardy MA
    Transplant Proc; 1990 Apr; 22(2):844. PubMed ID: 2109414
    [No Abstract]   [Full Text] [Related]  

  • 7. Prevention of autoimmune recurrence and rejection by adenovirus-mediated CTLA4Ig gene transfer to the pancreatic graft in BB rat.
    Uchikoshi F; Yang ZD; Rostami S; Yokoi Y; Capocci P; Barker CF; Naji A
    Diabetes; 1999 Mar; 48(3):652-7. PubMed ID: 10078573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of islet graft destruction in diabetic mice and rats by temporary anti-IL-2 receptor therapy: comparison of different strategies.
    Kuttler B; Mathieu C; Bulfone-Paus S; Bouillon R; Diamantstein T; Hahn HJ
    Transplant Proc; 1998 Dec; 30(8):4140-2. PubMed ID: 9865327
    [No Abstract]   [Full Text] [Related]  

  • 9. Cell-mediated cytotoxicity of peripheral lymphocytes as a new approach to early diagnosis of ongoing allograft rejection.
    Kuttler B; Wanka H; Hahn HJ
    Transplant Proc; 1994 Apr; 26(2):730-1. PubMed ID: 8171629
    [No Abstract]   [Full Text] [Related]  

  • 10. Complete protection of islets against allorejection and autoimmunity by a simple barium-alginate membrane.
    Duvivier-Kali VF; Omer A; Parent RJ; O'Neil JJ; Weir GC
    Diabetes; 2001 Aug; 50(8):1698-705. PubMed ID: 11473027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin 2 receptor targeted immunotherapy in the prevention of autoimmune beta-cell destruction as observed in diabetic BB/OK rats grafted with BB/OK rat islets.
    Hahn HJ; Kauert C; Dunger A; Kuttler B; Diamantstein T
    Autoimmunity; 1989; 5(1-2):139-42. PubMed ID: 2519014
    [No Abstract]   [Full Text] [Related]  

  • 12. Intrathymic islet allografts prevent hyperglycemia and autoimmune beta-cell destruction in BB rats following transplantation in the prediabetic period.
    Brayman KL; Nakai I; Field J; Lloveras JJ; Farney A; Najarian JS; Sutherland DE
    Transplant Proc; 1993 Feb; 25(1 Pt 1):284-5. PubMed ID: 8438301
    [No Abstract]   [Full Text] [Related]  

  • 13. The use of granzyme A as a marker of heart transplant rejection in cyclosporine or anti-CD4 monoclonal antibody-treated rats.
    Chen RH; Ivens KW; Alpert S; Billingham ME; Fathman CG; Flavin TF; Shizuru JA; Starnes VA; Weissman IL; Griffiths GM
    Transplantation; 1993 Jan; 55(1):146-53. PubMed ID: 8420039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nondepleting anti-CD4 and soluble interleukin-1 receptor prevent autoimmune destruction of syngeneic islet grafts in diabetic NOD mice.
    Drage M; Zaccone P; Phillips JM; Nicoletti F; Dawson J; Andrew Bradley J; Cooke A
    Transplantation; 2002 Sep; 74(5):611-9. PubMed ID: 12352875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological reactivity of diabetes-prone BB/OK rats to syngeneic antigens. Effect on beta-cell destruction and diabetes onset.
    Schröder D; Schmidt S; Klöting I; Honig A; Lucke S; Hehmke B; Schlosser M
    Adv Exp Med Biol; 1997; 426():345-53. PubMed ID: 9544293
    [No Abstract]   [Full Text] [Related]  

  • 16. Both CD4(+)and CD8(+)T cells are required for IFN-gamma gene expression in pancreatic islets and autoimmune diabetes development in biobreeding rats.
    El-Sheikh A; Suarez-Pinzon WL; Power RF; Rabinovitch A
    J Autoimmun; 1999 Mar; 12(2):109-19. PubMed ID: 10047431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD4-targeted therapy induces "infectious" tolerance to cardiac allografts in sensitized rat recipients.
    Onodera K; Lehmann M; Volk HD; Sayegh MH; Kupiec-Weglinski JW
    Transplant Proc; 1997 May; 29(3):1907-8. PubMed ID: 9142316
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of autoimmune destruction and rejection on the function of transplanted islands of Langerhans in spontaneous diabetes in the BB rat].
    Wöhrle M; Naji A; Barker CF; Federlin K
    Immun Infekt; 1987 Nov; 15(6):224-8. PubMed ID: 3125104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tacrolimus treats ongoing allograft rejection by inhibiting interleukin-10 mediated functional cytotoxic cell infiltration.
    Ebbs A; Pan F; Wynn C; Erickson L; Kobayashi M; Jiang H
    Transplant Proc; 2002 Aug; 34(5):1378-81. PubMed ID: 12176404
    [No Abstract]   [Full Text] [Related]  

  • 20. Depleting anti-CD4 monoclonal antibody cures new-onset diabetes, prevents recurrent autoimmune diabetes, and delays allograft rejection in nonobese diabetic mice.
    Makhlouf L; Grey ST; Dong V; Csizmadia E; Arvelo MB; Auchincloss H; Ferran C; Sayegh MH
    Transplantation; 2004 Apr; 77(7):990-7. PubMed ID: 15087759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.